You can buy or sell InflaRx and other stocks, options, ETFs, and crypto commission-free!
InflaRx N.V. Common Stock, also called InflaRx, is a biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Read More Its pipeline includes IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
52 Week High
52 Week Low
Simply Wall StMar 8
Do Insiders Own Lots Of Shares In InflaRx N.V. (NASDAQ:IFRX)?
Every investor in InflaRx N.V. (NASDAQ:IFRX) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. I quite like to see at least a little bit of insider ownership. As Charlie Munger said ‘Show me the incentive and I will show you the outcome.’ InflaRx has a market capitalization of US$1.1b, so we would expect some institutional investors to have noticed the st...
Expected Mar 28, Pre-Market